| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |